WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

FDA opens comment on an electronic submission template for IDE applications Vincora wins an IDE to implant artificial chordae on a beating heart OrthoPediatrics clears a retrograde femur nail in 7 to 11 mm diameters Stryker closes its ZuriMED deal and takes FiberLocker into sports medicine X9 wins a Breakthrough designation for power-assisted dialysis cannulation adsilico raises 10 million pounds to test implants on virtual patients Smith+Nephew and J&J ortho merger talks collapse over who would run it Labcorp agrees to buy Millennium Health and its drug monitoring business Coreline Soft clears aortic measurement software, its 13th US clearance FDA opens comment on an electronic submission template for IDE applications Vincora wins an IDE to implant artificial chordae on a beating heart OrthoPediatrics clears a retrograde femur nail in 7 to 11 mm diameters Stryker closes its ZuriMED deal and takes FiberLocker into sports medicine X9 wins a Breakthrough designation for power-assisted dialysis cannulation adsilico raises 10 million pounds to test implants on virtual patients Smith+Nephew and J&J ortho merger talks collapse over who would run it Labcorp agrees to buy Millennium Health and its drug monitoring business Coreline Soft clears aortic measurement software, its 13th US clearance

FDA Guidance

FDA opens comment on an electronic submission template for IDE applications

MedDevice Startups Staff · 3 hrs ago · 2 min read · Via FDA guidance document

FDA opened comment on a draft guidance that would put Investigational Device Exemption applications on an electronic submission template. The Federal Register notice ran October 28. Comments close December 28, 2026 under docket FDA-2026-D-11188.

The draft points sponsors at the resources and content FDA has already published for electronic IDE submissions, and describes the template as a guided preparation tool rather than a new content requirement. It carries the usual draft markings: for comment purposes only, and not for implementation. FDA says a final version would set the timetable for the further standards it intends to establish.

For a company heading into its first trial, this is the IDE following the path marketing submissions already took. What FDA asks for does not change. How it has to be packaged eventually will, and a sponsor that assembles its IDE around the template now avoids reformatting a live submission later.

Questions & Answers

What is the FDA draft guidance on electronic submission templates for IDE applications?

It is a draft guidance FDA published on October 28, 2026 under docket FDA-2026-D-11188. It describes the resources and content for submitting an Investigational Device Exemption application electronically, and frames the template as a guided submission preparation tool.

When do comments close on FDA docket FDA-2026-D-11188?

Comments on FDA's draft guidance for electronic IDE submission templates close December 28, 2026.

Does the FDA electronic IDE submission template guidance apply now?

No. FDA marked the October 28, 2026 document for comment purposes only and not for implementation. The agency says a final version would set a timetable for the standards it plans to establish.

← Back to Regulatory